Skip to main content

Vascular Anomalies

  • Chapter
  • First Online:
Case-Based Inpatient Pediatric Dermatology

Abstract

Vascular anomalies represent a diverse group of entities, each with unique natural history and associated complications. To meet the needs of this challenging population, many referral centers now have interdisciplinary clinics devoted specifically to vascular lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg. 1982;70(1):120–1.

    Article  CAS  PubMed  Google Scholar 

  2. Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor 3rd CC. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Drolet BA, Trenor 3rd CC, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285–91.

    Article  PubMed  Google Scholar 

  4. Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, Taïeb A, Stalder JF, Escande JP. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997;130(4):631–40.

    Article  CAS  PubMed  Google Scholar 

  5. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100(6):1377–86.

    Article  CAS  PubMed  Google Scholar 

  6. Paller AS, Mancini AJ. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. Philadelphia: Elsevier; 2011.

    Google Scholar 

  7. Gruman A, Liang MG, Mulliken JB, Fishman SJ, Burrows PE, Kozakewich HP, Blei F, Frieden IJ. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 2005;52(4):616–22.

    Article  PubMed  Google Scholar 

  8. O’Rafferty C, O’Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol. 2015;171(1):38–51.

    Article  PubMed  Google Scholar 

  9. Osio A, Fraitag S, Hadj-Rabia S, Bodemer C, de Prost Y, Hamel-Teillac D. Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature. Arch Dermatol. 2010;146(7):758–63.

    Article  PubMed  Google Scholar 

  10. Kai L, Wang Z, Yao W, Dong K, Xiao X. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma. J Cancer Res Clin Oncol. 2014;140(3):471–6.

    Article  CAS  PubMed  Google Scholar 

  11. Blatt J, Stavas J, Moats-Staats B, Woosley J, Morrell DS. Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer. 2010;55(7):1396–8.

    Article  PubMed  Google Scholar 

  12. Greene AK, Liu AS, Mulliken JB, Chalache K, Fishman SJ. Vascular anomalies in 5,621 patients: guidelines for referral. J Pediatr Surg. 2011;46(9):1784–9.

    Article  PubMed  Google Scholar 

  13. Mathes EF, Haggstrom AN, Dowd C, Hoffman WY, Frieden IJ. Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic. Arch Dermatol. 2004;140(8):979–83.

    Article  PubMed  Google Scholar 

  14. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68(2):198–201.

    Article  CAS  PubMed  Google Scholar 

  15. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861–7.

    Article  PubMed  Google Scholar 

  16. Lee A, Driscoll D, Gloviczki P, Clay R, Shaughnessy W, Stans A. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics. 2005;115(3):744–9.

    Article  PubMed  Google Scholar 

  17. Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbé D, Barrellier MT, Vanwijck R, Vikkula M, Boon LM. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873–7.

    Article  PubMed  Google Scholar 

  18. Rodríguez-Mañero M, Aguado L, Redondo P. Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol. 2010;146(12):1347–52.

    Article  PubMed  Google Scholar 

  19. Nguyen JT, Koerper MA, Hess CP, Dowd CF, Hoffman WY, Dickman M, Frieden IJ. Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences. Pediatr Dermatol. 2014;31(5):556–60.

    Article  PubMed  Google Scholar 

  20. Maguiness S, Koerper M, Frieden I. Relevance of D-dimer testing in patients with venous malformations. Arch Dermatol. 2009;145(11):1321–4.

    Article  PubMed  Google Scholar 

  21. Lance EI, Sreenivasan AK, Zabel TA, Kossoff EH, Comi AM. Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol. 2013;28(2):213–8.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138(12):1567–76.

    Article  PubMed  Google Scholar 

  23. Suh KY, Frieden IJ. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol. 2010;146(9):971–6.

    Article  PubMed  Google Scholar 

  24. Johnson EF, Smidt AC. Not just a diaper rash: LUMBAR syndrome. J Pediatr. 2014;164(1):208–9.

    Article  PubMed  Google Scholar 

  25. Stockman A, Boralevi F, Taïeb A, Léauté-Labrèze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology. 2007;214(1):40–5.

    Article  PubMed  Google Scholar 

  26. Girard C, Bigorre M, Guillot B, Bessis D. PELVIS syndrome. Arch Dermatol. 2006;142(7):884–8.

    Article  PubMed  Google Scholar 

  27. Iacobas I, Burrows PE, Frieden IJ, Liang MG, Mulliken JB, Mancini AJ, Kramer D, Paller AS, Silverman R, Wagner AM, Metry DW. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157(5):795–801.

    Article  PubMed  Google Scholar 

  28. Drolet BA, Chamlin SL, Garzon MC, Adams D, Baselga E, Haggstrom AN, Holland KE, Horii KA, Juern A, Lucky AW, Mancini AJ, McCuaig C, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Frieden IJ. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr. 2010;157(5):789–94.

    Article  PubMed  Google Scholar 

  29. de Graaf M, Pasmans SG, van Drooge AM, Nievelstein RA, Gooskens RH, Raphael MF, Breugem CC. Associated anomalies and diagnostic approach in lumbosacral and perineal haemangiomas: case report and review of the literature. J Plast Reconstr Aesthet Surg. 2013;66(1):e26–8.

    Article  PubMed  Google Scholar 

  30. Willihnganz-Lawson K, Gordon J, Perkins J, Shnorhavorian M. Genitourinary and perineal vascular anomalies in children: a Seattle children’s experience. J Pediatr Urol. 2015;11(4):227.e1–6.

    Article  Google Scholar 

  31. Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146(11):1235–9.

    Article  PubMed  Google Scholar 

  32. Maguiness SM, Frieden IJ. Management of difficult infantile haemangiomas. Arch Dis Child. 2012;97(3):266–71.

    Article  PubMed  Google Scholar 

  33. Thomas J, Kumar P, Kumar DD. Ulcerated infantile haemangioma of buttock successfully treated with topical timolol. J Cutan Aesthet Surg. 2013;6(3):168–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Michel JL, Patural H. Response to oral propranolol therapy for ulcerated hemangiomas in infancy. Arch Pediatr. 2009;16(12):1565–8.

    Article  PubMed  Google Scholar 

  35. Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.

    Article  PubMed  Google Scholar 

  36. Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30(2):182–91.

    Article  PubMed  Google Scholar 

  37. Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol. 2002;19(1):5–11.

    Article  PubMed  Google Scholar 

  38. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001;107(7):1647–54.

    Article  CAS  PubMed  Google Scholar 

  39. Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, Burrows PE, Perez-Atayde AR, Kozakewich HP. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003;6(6):495–510.

    Article  PubMed  Google Scholar 

  40. Nasseri E, Piram M, McCuaig CC, Kokta V, Dubois J, Powell J. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 2014;70(1):75–9.

    Article  PubMed  Google Scholar 

  41. Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996;128(3):329–35.

    Article  CAS  PubMed  Google Scholar 

  42. Maguiness S, Uihlein LC, Liang MG, Kozakewich H, Mulliken JB. Rapidly involuting congenital hemangioma with fetal involution. Pediatr Dermatol. 2015;32(3):321–6.

    Article  PubMed  Google Scholar 

  43. Elia D, Garel C, Enjolras O, Vermouneix L, Soupre V, Oury JF, Guibaud L. Prenatal imaging findings in rapidly involuting congenital hemangioma of the skull. Ultrasound Obstet Gynecol. 2008;31(5):572–5.

    Article  CAS  PubMed  Google Scholar 

  44. Fadell 2nd MF, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2011;41(8):1057–60.

    Article  PubMed  Google Scholar 

  45. Vildy S, Macher J, Abasq-Thomas C, Le Rouzic-Dartoy C, Brunelle F, Hamel-Teillac D, Duteille F, Perret C, Perrot P, Cassagnau E, Chauty-Frondas A, Aubert H, Barbarot S. Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. JAMA Dermatol. 2015;151(4):422–5.

    Article  PubMed  Google Scholar 

  46. Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009;44(1):125–33.

    Article  PubMed  Google Scholar 

  47. Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg. 2012;47(1):165–70.

    Article  PubMed  Google Scholar 

  48. Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement G, Mulliken JB, Fishman SJ. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007;42(1):62–7.

    Article  PubMed  Google Scholar 

  49. Boon LM, Burrows PE, Paltiel HJ, Lund DP, Ezekowitz RA, Folkman J, Mulliken JB. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996;129(3):346–54.

    Article  CAS  PubMed  Google Scholar 

  50. Zenzen W, Perez-Atayde AR, Elisofon SA, Kim HB, Alomari AI. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol. 2009;39(10):1118–23.

    Article  PubMed  Google Scholar 

  51. North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity. Arch Dermatol. 2004;140(5):599–606.

    Article  PubMed  Google Scholar 

  52. Prasad V, Fishman SJ, Mulliken JB, Fox VL, Liang MG, Klement G, Kieran MW, Burrows PE, Waltz DA, Powell J, Dubois J, Levy ML, Perez-Atayde AR, Kozakewich HP. Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol. 2005;8(4):407–19.

    Article  PubMed  Google Scholar 

  53. Marron M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M. Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer. 2009;52(4):531–4.

    Article  Google Scholar 

  54. Glick ZR, Frieden IJ, Garzon MC, Mully TW, Drolet BA. Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol. 2012;67(5):898–903.

    Article  PubMed  Google Scholar 

  55. Nahm WK1, Moise S, Eichenfield LF, Paller AS, Nathanson L, Malicki DM, Friedlander SF. Venous malformations in blue rubber bleb nevus syndrome: variable onset of presentation. J Am Acad Dermatol. 2004 May;50(5 Suppl):S101-6.

    Google Scholar 

  56. Esparza EM, Deutsch G, Stanescu L, Weinberger E, Brandling-Bennett HA, Sidbury R. Multifocal lymphangioendotheliomatosis with thrombocytopenia: phenotypic variant and course with propranolol, corticosteroids, and aminocaproic acid. J Am Acad Dermatol. 2012;67(1):e62–4.

    Article  PubMed  Google Scholar 

  57. Kline RM, Buck LM. Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer. 2009;52(4):534–6.

    Article  PubMed  Google Scholar 

  58. Droitcourt C, Boccara O, Fraitag S, Favrais G, Dupuy A, Maruani A. Multifocal lymphangioendotheliomatosis with thrombocytopenia: clinical features and response to sirolimus. Pediatrics. 2015;136(2):e517–22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sheilagh M. Maguiness MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Maguiness, S.M., Boull, C.L. (2016). Vascular Anomalies. In: Hogeling, M. (eds) Case-Based Inpatient Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31569-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31569-0_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31567-6

  • Online ISBN: 978-3-319-31569-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics